Lung Cancer Pill Holds Promise For Those Who Pass Test

Only people with lung cancer that tests positive for a particular genetic variation are candidates for treatment with Pfizer's twice-a-day cancer pill called Xalkori. Most of those who qualified in clinical tests saw dramatic shrinkage of their tumors.